Skip to main content

Diseases of the Liver

  • Chapter
Family Medicine
  • 14 Accesses

Abstract

The liver is vulnerable to injury from viral agents and to exposure to ingested and inhaled toxins. The usual result of injury is an inflammatory reaction known as hepatitis. Hepatitis may be classified as acute or chronic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lednar WM, Lemon SM, Kirkpatrick JW, et al. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 1985;122:226–33.

    PubMed  CAS  Google Scholar 

  2. McIntyre M. Clinical presentation of acute viral hepatitis. Br Med Bull 1990;46:533–47.

    PubMed  CAS  Google Scholar 

  3. Tozan N, Forbes A, Anderson MG, Murray-Lyon IM. Safety of alcohol consumption after acute viral hepatitis. Lancet 1991;337: 1079–80.

    Article  Google Scholar 

  4. Farero MS, Maynard JE, Leger RT, et al. Guidelines for the care of patients hospitalized with viral hepatitis. Ann Intern Med 1979;91:872–4.

    Article  Google Scholar 

  5. Stevens CE, Beasley RP, Tsui J, Lee WD. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771–4.

    Article  PubMed  CAS  Google Scholar 

  6. Wright R, Millward-Sadler GH, Bull FG. Acute viral hepatitis. In: Wright RW, Millward-Sadler GH, editors. Liver and biliary disease. London: Bailliere Tindall, 1985:677–767.

    Google Scholar 

  7. U.S. Preventive Services Task Force. Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions. Baltimore: Williams & Wilkins, 1990:369–72.

    Google Scholar 

  8. McMahon BJ, Alward WLM, Hall DB, et al. Acute hepatitis B infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599–603.

    Article  PubMed  CAS  Google Scholar 

  9. Foutch PG, Carey WD, Tabor E, et al. Concomitant hepatitis B surface antigen and antibody in thirteen patients. Ann Intern Med 1983;99:460–3.

    Article  PubMed  CAS  Google Scholar 

  10. Choo QL, Weiner AJ, Overby LR, et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990;46:423–41.

    PubMed  CAS  Google Scholar 

  11. Dienstag JL. Non-A, non-B hepatitis: recognition, epidemiology and clinical features. Gastroenterology 1983;83:439–62.

    Google Scholar 

  12. Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;2:294–7.

    Article  PubMed  CAS  Google Scholar 

  13. Brotman B, Boehle W, Prince AM. Absence of perinatal transmission of blood-borne non-A, non-B hepatitis virus by chimpanzees with acute and chronic infection. J Med Virol 1989;28:13–15.

    Article  PubMed  CAS  Google Scholar 

  14. Villarejos MV, Visona KA, Eduarte CA, et al. Evidence of viral hepatitis other than type A or type B among persons in Costa Rica. N Engl J Med 1975;293:1350–2.

    Article  PubMed  CAS  Google Scholar 

  15. Hoofnagle JH, Alter HJ. In: Vyas GN, Dienstag JL, Hoofnagle JH, editors. Viral hepatitis and liver disease. Orlando, FL: Grune & Stratton, 1984:97–113.

    Google Scholar 

  16. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494–500.

    Article  PubMed  CAS  Google Scholar 

  17. Williams AE, Dodd RY. The serology of hepatitis C virus in relation to post-transfusion hepatitis. Ann Clin Lab Sci 1990;20: 192–9.

    PubMed  CAS  Google Scholar 

  18. Koretz RL, Stone O, Gitnick GL. The long-term course of non-A, non-B post-transfusion hepatitis. Gastroenterology 1980;79:893–8.

    PubMed  CAS  Google Scholar 

  19. Purcell RH. Enterically transmitted non-A, non-B hepatitis. Prog Liver Dis 1990;9:497–504.

    PubMed  CAS  Google Scholar 

  20. Stevens CE, Toy PT, Tong MJ, et al. Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization. JAMA 1985;253:1740–5.

    Article  PubMed  CAS  Google Scholar 

  21. Czaja AJ, Ammon HV, Summerskill WH. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid induced remission. Gastroenterology 1980;78:518–23.

    PubMed  CAS  Google Scholar 

  22. Korenman J, Baker B, Waggoner J, et al. Long term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629–34.

    Article  PubMed  CAS  Google Scholar 

  23. Bisceglie AM, Hoofnagle JH. Antiviral therapy of chronic hepatitis. Am J Gastroenterol 1990;85:650–4.

    PubMed  Google Scholar 

  24. Centers for Disease Control, Advisory Committee on Immunization Practices. Recommendations for protection against viral hepatitis. MMWR 1985;34:313–24, 329–35.

    Google Scholar 

  25. Rustgi VK, Hoofnagle JH. Viral hepatitis during pregnancy. Semin Liver Dis 1987;7(1):40–46.

    Article  PubMed  CAS  Google Scholar 

  26. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. JAMA 1990;263:1218–22.

    Article  PubMed  CAS  Google Scholar 

  27. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 1991;40(RR-13):1–19.

    Google Scholar 

  28. Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 1988;319:1639–50.

    Article  PubMed  CAS  Google Scholar 

  29. Sorensen TIA, Orholm M, Bensten KD, et al. Prospective evaluation of alcohol abuse and alcoholic liver disease in men as predictors of development of cirrhosis. Lancet 1984;1:241–3.

    Article  Google Scholar 

  30. Norton R, Batey R, Dwyer R, MacMahon S. Alcohol consumption and the risk of alcohol-related cirrhosis in women. BMJ 1987; 295:80–2.

    Article  PubMed  CAS  Google Scholar 

  31. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis 1988;8:12–5.

    Article  PubMed  CAS  Google Scholar 

  32. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948–63.

    Article  PubMed  CAS  Google Scholar 

  33. Simonetti RG, Calogero C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 1992;116:97–102.

    Article  PubMed  CAS  Google Scholar 

  34. Dusheiko GM. Hepatocellular carcinoma associated with chronic viral hepatitis: aetiology, diagnosis and treatment. Br Med Bull 1990;46:492–511.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Parchman, M.L. (1994). Diseases of the Liver. In: Taylor, R.B. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4005-9_92

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4005-9_92

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-4007-3

  • Online ISBN: 978-1-4757-4005-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics